The American Journal of Managed Care1h
Genetic Causal Link Found Between RA, Increased Fracture Risk
A genetic causal link between rheumatoid arthritis (RA) and an increased risk of traumatic and osteoporotic fractures ...
Rheumatoid arthritis causally linked to prostate cancer
Genetically predicted rheumatoid arthritis (RA) is causally associated with prostate cancer (PCa), according to a study ...
Everyday Health8d
Understanding Rheumatoid Arthritis Flare-Ups: Symptoms, Triggers, and Management Techniques
Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...
dermatologyadvisor2h
Anti-RA33 Antibodies Found in Lyme Disease, No Clinical Specificity
A significant percentage of patients with Lyme arthritis and other Lyme disease manifestations were positive for anti-RA33 antibodies.
Too Old to Operate3d
GPs Perception of Collaborative Care in RA Management
The following is a summary of “Exploring the general practitioners’ perception of the inter-professional care of rheumatoid ...
Too Old to Operate1d
Targeted Synthetic DMARDs in RA and CKD
The following is a summary of “Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease,” published in the January 2025 issue of ...
Medscape10d
Wildfire Smoke Exposure Raises Risk for Rheumatoid Arthritis and Related Lung Disease
A large case-control study found that high levels of fire smoke with particulate matter smaller than 2.5 microns doubled the ...
Promising Expansion in Rheumatoid Arthritis Drives Buy Rating for Spyre Therapeutics
BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...
bernama8d
RHEUMATOID ARTHRITIS: WOMEN MORE AT RISK
Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune ...
Healio8d
Odds of DMARD-free remission in rheumatoid arthritis may depend on biological DMARD use
Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...
LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)
LPX-TI641 is a novel, orally bioavailable, potent small-molecule immunomodulator that restores immune tolerance by targeting multiple pathways implicated in autoimmune diseases.Topline Phase 1 ...